Zobrazeno 1 - 4
of 4
pro vyhledávání: '"N. N. Pakhtusov"'
Autor:
N. N. Pakhtusov, A. O. Yusupova, A. S. Lishuta, O. A. Slepova, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 1, Pp 26-33 (2023)
Aim. To study the levels of pro-inflammatory biomarkers in patients with obstructive and non-obstructive coronary artery disease (CAD), to identify possible differences for diagnosing the degree of coronary obstruction.Material and methods. The obser
Externí odkaz:
https://doaj.org/article/4d37bc8352a542808401d12feec6ad6d
Autor:
N. N. Pakhtusov, A. O. Yusupova, K. A. Zhbanov, A. A. Shchedrygina, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 6, Pp 630-637 (2023)
Aim. To study the levels of fibrosis markers in patients with stable coronary artery disease (CAD) and various types of coronary artery (CA) lesions (obstructive and non-obstructive), to identify possible differences for diagnosing the types of coron
Externí odkaz:
https://doaj.org/article/50de31acbeaa49af9d1f6f4b98918670
Publikováno v:
Kardiologiia. 61:52-58
Aim To determine levels of markers for endothelial dysfunction and inflammation, endothelin-1, E-selectin, and tumor necrosis factor α (TNF-α) in patients with ischemic heart disease (IHD) and non-obstructive and obstructive coronary artery (CA) di
Publikováno v:
European Heart Journal. 42
Aim of the study To analyze the association of biological markers levels of endothelial dysfunction and fibrosis with macro- and microcirculation alterations in patients with obstructive and nonobstructive coronary artery disease (CAD) and type 2 dia